Pablo Ryan

Instituto de Investigación Sanitaria Gregorio Marañón

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Verónica Briz

Head of HIV and viral hepatitis coinfection group (COVIHEP)

Institute of Health Carlos III

SPAIN

View details

Carlos Rodríguez-Gallego

Associated Professor

Universidad Fernando Pessoa Canarias

SPAIN

View details

Claudia Palladino

Universidade de Lisboa Faculdade de Farmácia

PORTUGAL

View details

Gema Díaz Gil

Profesor Titular

Universidad Rey Juan Carlos

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pablo Ryan

Research Interests

Explore related searches

Contact this professor

Articles (20)

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

Post-COVID-19 Pain Is Not Associated with DNA Methylation Levels of the <i>ACE2</i> Promoter in COVID-19 Survivors Hospitalized Due to SARS-CoV-2 Infection

DNA Methylation Levels of the ACE2 Promoter Are Not Associated with Post-COVID-19 Symptoms in Individuals Who Had Been Hospitalized Due to COVID-19

Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?

Inflammatory Polymorphisms (IL-6 <i>rs1800796</i>, IL-10 <i>rs1800896</i>, TNF-α <i>rs1800629</i>, and IFITM3 <i>rs12252</i>) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors

Inflammatory Polymorphisms (IL-6 <i>rs1800796</i>, IL-10 <i>rs1800896</i>, TNF-α <i>rs1800629</i>, and IFITM3 <i>rs12252</i>) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors

<i>HLA-A11:01</i> and <i>HLA-C04:01</i> are associated with severe COVID-19

A second update on mapping the human genetic architecture of COVID-19

Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain

Diagnostic Performance of the HCV Core Antigen Test To Identify Hepatitis C in HIV-Infected Patients: a Systematic Review and Meta-Analysis

Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study

Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance

A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid

Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D

Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care

Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817)

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization

Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort

Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation

Collaborators (4)

Verónica Briz

Carlos Rodríguez-Gallego

Claudia Palladino

Gema Díaz Gil

Make your next move.